Business
BioElectronics to Showcase Products at World's Largest Medical Tradeshow
BioElectronics to Showcase Products at World's Largest Medical Tradeshow.
About this update from Bioelectronics Corp.
[{"type":"text","content":"\n \n \n BioElectronics to Showcase Products at World's Largest Medical Tradeshow\n \n \nBioElectronics to Showcase Products at World's Largest Medical Tradeshow\n \n FREDERICK, MD--(Marketwired - Nov 9, 2017) - BioElectronics Corporation (OTC PINK: BIEL) is the maker of advanced, non-prescription pain management medical devices. The company announced today that it will showcase its range of pain and inflammation reduction products at MEDICA 2017 in Germany, dubbed as the leading international tradeshow for the medical industry.\n The company will share a pavilion hosted by the State of Maryland with 10 other Maryland-based companies in Hall 16, Booth C-18. The tradeshow is set to take place in Dusseldorf, Germany from November 13-16 and will focus on advancements critical to the healthcare industry. This is an excellent platform for a global audience to learn more about the drug-free, wearable neuromodulation medical devices manufactured only by BioElectronics Corporation.\n The company's product line includes RecoveryRx® for postoperative and chronic wounds, Allay®, Menstrual Pain Therapy, Smart Insole™, for Heel Pain, and the FDA-cleared ActiPatch® Musculoskeletal Pain Therapy, which provides:\n \n \n Drug-free therapy\n \n No harmful side effects\n \n \nAffordable therapy -- 720-hours with on/off switch and sells for USD 29.99, or USD 0.04 per hour of therapy.\n \nEvidence for mechanism of action and clinical evidence, which can be viewed at http://www.actipatch.com/support/for-medical-professionals/.\n \n 65% of users attain a 57% VAS pain score reduction \n \n \nReduced medication use\n \n 50% reduction in medication use, including opioids\n \n41% reduction in chronic pain sufferers' \"special needs cost\" \n \n \nEffective as a standalone therapy OR as adjunctive\n \n Alternative to narcotic medication\n \n \nHigh consumer acceptance\n \n ActiPatch users report increased physical activity & improved sleep quality \n \n \nAward-winning 7-Day Trial marketability strategy\n \n \n Ms. Erin Sanders, International Sales Manager at BioElectronics, will represent the company and seek new international distributors. \"Our current, successful international distributor agreements were forged at prior MEDICA shows. We wish to continue our streak this year and acquire additional international markets,\" Ms. Sa...